DE PONTI, FABRIZIO
DE PONTI, FABRIZIO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
2024 Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Raschi, E.
Enhancing therapeutic reasoning: key insights and recommendations for education in prescribing
2024 Hartjes, M. G.; Richir, M. C.; Cazaubon, Y.; Donker, E. M.; van Leeuwen, E.; Likic, R.; Pers, Y. M.; Piët, J. D.; De Ponti, F.; Raasch, W.; van Rosse, F.; Rychlícková, J.; Sanz, E. J.; Schwaninger, M.; Wallerstedt, S. M.; de Vries, T. P. G. M.; van Agtmael, M. A.; Tichelaar, J.
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
2024 Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J.
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution
2024 Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
2024 Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Joshi, N.; Khouri, C.
The European List of Key Medicines for Medical Education: A Modified Delphi Study
2024 Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2024 Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.
Using artificial intelligence to create diverse and inclusive medical case vignettes for education
2024 Bakkum, Michiel J; Hartjes, Mariëlle G; Piët, Joost D; Donker, Erik M; Likic, Robert; Sanz, Emilio; de Ponti, Fabrizio; Verdonk, Petra; Richir, Milan C; van Agtmael, Michiel A; Tichelaar, Jelle
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity
2023 Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle
Antipsychotics and Drug-Induced Liver Injury
2023 Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; De Ponti, Fabrizio
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
2023 Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E.
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project
2023 Bakkum, Michiel J; Donker, Erik M; Spitaleri Timpone, Pietro; Hagen, Charlotte A M; Richir, Milan C; van Agtmael, Michiel A; De Ponti, Fabrizio; Tichelaar, Jelle
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E.
Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice
2023 Raschi, Emanuel; Poluzzi, Elisabetta; De Ponti, Fabrizio
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
2022 Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J.; Poluzzi E.
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems
2022 Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F.
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
2022 Raschi E.; Diemberger I.; Sabatino M.; Poluzzi E.; De Ponti F.; Potena L.
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants
2022 Martini, Silvia; Vitali, Francesca; Capelli, Irene; Donadei, Chiara; Raschi, Emanuel; Aiello, Valeria; Corvaglia, Luigi; De Ponti, Fabrizio; Poluzzi, Elisabetta; Galletti, Silvia